4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Koike, T; Kusunoki, M; Lian, X; Liao, D; Tang, C; Tsutsumi, K; Wang, Z; Xi, S; Yang, Y; Yin, W | 1 |
| Cai, M; Hou, H; Li, J; Li, Q; Liao, D; Liu, Y; Tsutsumi, K; Wang, Z; Xiao, J; Yin, W; Zhang, C | 1 |
2 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Diabetes Mellitus
| Article | Year |
|---|---|
NO-1886 decreases ectopic lipid deposition and protects pancreatic beta cells in diet-induced diabetic swine.
Topics: Animals; Benzamides; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Hypoglycemic Agents; Insulin Resistance; Islets of Langerhans; Lipid Metabolism; Liver; Male; Models, Animal; Muscle, Skeletal; Myocardium; Organophosphorus Compounds; Swine, Miniature | 2004 |
Effects of NO-1886 on inflammation-associated cytokines in high-fat/high-sucrose/high-cholesterol diet-fed miniature pigs.
Topics: Animals; Atherosclerosis; Benzamides; Cholesterol, Dietary; Cytokines; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Glucose Tolerance Test; Hypolipidemic Agents; Inflammation; Insulin; Insulin Resistance; Lipids; Male; Organophosphorus Compounds; Sucrose; Swine; Swine, Miniature; Tunica Intima | 2006 |